Frank, Rimerman Advisors LLC Astrazeneca PLC Transaction History
Frank, Rimerman Advisors LLC
- $1.4 Billion
- Q2 2024
A detailed history of Frank, Rimerman Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 9,794 shares of AZN stock, worth $758,741. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,794
Previous 38
25673.68%
Holding current value
$758,741
Previous $2,000
38050.0%
% of portfolio
0.05%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...